36308:PAIN MANAGEMENT PANEL 308-A

Print View Attached Docs:Physician Update: PtProtect Pain Medication Management Program Monitors Patient Compliance
36308:PAIN MANAGEMENT PANEL 308-A
Alias Names: PMP308-A
Methodology: Enzyme Immunoassay (EIA) / Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) / Gas Chromatography/Mass Spectrometry (GC/MS)
Edit Date: 6/11/2010
Components: Amphetamines / Barbiturates / Benzodiazepines / Cocaine / Ethyl Alcohol / Methadone / Propoxyphene / Phencyclidine (PCP) / Carisoprodol and Metabolite (Meprobamate) / Tramadol and Metabolite / Opioids (unconjugated: Oxycodone/Oxymorphone/Hydrocodone/Hydromorphone/Codeine/Morphine/Fentanyl/Norfentanyl/6-monoacetylmorphine/Meperidine)
Performed: Daily
Released: In 72 hours
CPT Code: 80101 x8 / 83925 x10 / 80299 x3 / 83805
Specimen Collection Details
Collection: Urine in a clean plastic container. Avoid ethanol-containing hand cleaning lotions prior to collection.
Handling: Send to laboratory immediately.
Stability: 5 days ambient. Refrigerate if transport is delayed.
Standard Volume: 30 mL urine
Minimum Volume: 30 mL urine
Transport: Ambient or refrigerated.
Comments: Panel consists of DAS-8, Carisoprodol, Tramadol, and Opioid Panel. This panel is for evaluation in clinical pain treatment.
Rejection Criteria: Insufficient quantity; mislabeled or unlabeled specimen.